Vaccines, acquired business and recent launches drive Novartis's Q1 growth
This article was originally published in Scrip
Executive Summary
Novartis began 2010 in much the same way as it ended 2009, with its net income for the quarter increasing by nearly a half to $2.9 billion. Group sales rose by 25%, or by 18% at constant currency rates, to $12.1 billion.